Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance

Summary Antibodies directed against protein S (anti-ProtS) may be involved in the development of thrombosis in patients with the antiphospholipid syndrome. We assessed the prevalence and clinical significance of anti-ProtS and evaluated their immunological characteristics in 184 patients with SLE and 99 healthy donors. All patients were tested for IgG anti-ProtS by an in-house ELISA. Plasma levels and functional activity of protein S were also tested. Anti-ProtS were found in 57 patients (31%) and 4 healthy controls (4%). Patients with thrombosis had anti-ProtS more frequently than controls (29% vs 4%, OR 9.5 [95% CI 3.07-29.3], p<0.0001). Anti-ProtS were more frequent in patients with venous thrombosis and in those with arterial thrombosis, than in controls (41% vs. 4%, OR 16.5 [95% CI 5-54], p< 0.0001 and 23% vs. 4%, OR 7 [95%CI 2.1-23.5], p=0.0008, respective-ly). Patients with prematurity, preeclampsia and intra-uterine growth restriction had anti-ProtS more frequently than the control group (36%, 47% and 44% vs. 4%; OR 13.6 [95% CI 2.8-66], p=0.003, OR 21 [95% CI 5-86], p<0.0001 and OR 19 [95% CI 4-99], p=0.0014, respectively). Plasma levels of free protein S were not statistically different between patients with and without anti-ProtS and controls (77.9% [20.7-100] vs. 83.7% [52.7-100] vs. 89% [62-101], respectively). Free protein S functional activity was no different between subgroups (105% [48-230] in anti-ProtS positive vs. 123% [95-283] in anti-ProtS negative vs. 136% [60-174] in controls). Anti-ProtS are frequent in SLE patients with thrombosis and pregnancy morbidity. These antibodies do not interfere with free protein S in plasma since its level and/or functional activity are not impaired.

[1]  J. Matsuda,et al.  Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies , 1994, Annals of Hematology.

[2]  J. Merrill,et al.  Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome , 2002, Lupus.

[3]  Y. Kanakura,et al.  Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. , 2001, Clinical chemistry.

[4]  K. Dellagi,et al.  Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  H. K. Kim,et al.  Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[6]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[7]  J. Merrill,et al.  Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. , 1999, Thrombosis and haemostasis.

[8]  P. Morange,et al.  Acquired Protein S Deficiency, Likely due to Anti-PS Autoantibodies, following a Thrombotic Event in a Patient with a Systemic Lupus erythematosus , 1997, Thrombosis and Haemostasis.

[9]  R. Olds,et al.  The inherited basis of venous thrombosis , 1997, Pathology.

[10]  G. Hughes,et al.  Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. , 1996, British journal of rheumatology.

[11]  Ras Roubey,et al.  Antigenic Specificities of Antiphospholipid Autoantibodies: Implications for Clinical Laboratory Testing and Diagnosis of the Antiphospholipid Syndrome , 1996, Lupus.

[12]  M. Sorice,et al.  Inhibition of Protein S by Autoantibodies in Patients with Acquired Protein S Deficiency , 1996, Thrombosis and Haemostasis.

[13]  D. Isenberg,et al.  Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. , 1995, British journal of rheumatology.

[14]  S. Pierangeli,et al.  Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies. , 1994, American journal of clinical pathology.

[15]  G. Hughes.  The antiphospholipid syndrome: ten years on , 1993, The Lancet.

[16]  P. D. de Groot,et al.  Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? , 1993, Blood.

[17]  A. Parke,et al.  The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. , 1992, The American journal of medicine.

[18]  A. Berrebi,et al.  Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis , 1991, American journal of hematology.

[19]  D. Alarcón-Segovia,et al.  Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome. , 1991, The Journal of rheumatology.

[20]  J. Moreb,et al.  Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases. , 1989, The American journal of medicine.

[21]  K. High.  Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. , 1988, Archives of Pathology & Laboratory Medicine.

[22]  J. Griffin,et al.  Identification and quantitation of protein S in human platelets. , 1985, Blood.

[23]  C. Esmon,et al.  Recurrent venous thromboembolism in patients with a partial deficiency of protein S. , 1984, The New England journal of medicine.

[24]  C. Esmon,et al.  Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.

[25]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.